Clearbridge Investments Llc Decreased Core Mark Holding Co (CORE) Stake By $17.03 Million; Baker Bros Advisors LP Has Decreased Its Immunogen (IMGN) Stake

May 18, 2018 - By Ellis Scott

Core-Mark Holding Company, Inc. (NASDAQ:CORE) Logo

Baker Bros Advisors Lp decreased Immunogen Inc. (IMGN) stake by 4.65% reported in 2017Q4 SEC filing. Baker Bros Advisors Lp sold 125,000 shares as Immunogen Inc. (IMGN)’s stock rose 69.65%. The Baker Bros Advisors Lp holds 2.56 million shares with $16.43M value, down from 2.69 million last quarter. Immunogen Inc. now has $1.43B valuation. The stock decreased 0.09% or $0.01 during the last trading session, reaching $10.76. About 3.97M shares traded or 38.39% up from the average. ImmunoGen, Inc. (NASDAQ:IMGN) has risen 195.97% since May 18, 2017 and is uptrending. It has outperformed by 184.42% the S&P500.




Clearbridge Investments Llc decreased Core Mark Holding Co Inc (NASDAQ:CORE) stake by 23.1% reported in 2018Q1 SEC filing. Clearbridge Investments Llc sold 810,968 shares as Core Mark Holding Co Inc (NASDAQ:CORE)’s stock declined 31.11%. The Clearbridge Investments Llc holds 2.70 million shares with $57.40 million value, down from 3.51 million last quarter. Core Mark Holding Co Inc now has $858.46 million valuation. The stock increased 0.54% or $0.1 during the last trading session, reaching $18.6. About 510,929 shares traded or 44.45% up from the average. Core-Mark Holding Company, Inc. (NASDAQ:CORE) has declined 32.34% since May 18, 2017 and is downtrending. It has underperformed by 43.89% the S&P500.

Baker Bros Advisors Lp increased Abeona Therapeutics Inc. stake by 300,000 shares to 1.98 million valued at $31.45M in 2017Q4. It also upped Assembly Biosciences Inc. (NASDAQ:ASMB) stake by 72,727 shares and now owns 322,727 shares. Ascendis Pharma A/S was raised too.

More news for ImmunoGen, Inc. (NASDAQ:IMGN) were recently published by: Seekingalpha.com, which released: “ImmunoGen: An Extremely Promising ADC Therapeutic Innovator” on May 09, 2018. Streetinsider.com‘s article titled: “ImmunoGen (IMGN) option implied volatility, says to present data from FORWARD II trial at ASCO” and published on May 17, 2018 is yet another important article.

Among 9 analysts covering Immunogen (NASDAQ:IMGN), 6 have Buy rating, 1 Sell and 2 Hold. Therefore 67% are positive. Immunogen had 32 analyst reports since August 3, 2015 according to SRatingsIntel. The stock has “Hold” rating by Cowen & Co on Sunday, June 4. On Monday, March 26 the stock rating was maintained by Jefferies with “Buy”. As per Thursday, February 1, the company rating was maintained by Canaccord Genuity. The firm has “Outperform” rating given on Wednesday, July 29 by Oppenheimer. The company was maintained on Wednesday, October 28 by Leerink Swann. The stock has “Buy” rating by Jefferies on Sunday, August 6. The stock of ImmunoGen, Inc. (NASDAQ:IMGN) has “Buy” rating given on Tuesday, October 10 by Jefferies. The rating was maintained by Leerink Swann on Monday, May 2 with “Market Perform”. The firm earned “Buy” rating on Friday, September 8 by Jefferies. The rating was maintained by Jefferies on Monday, June 26 with “Buy”.

Since February 13, 2018, it had 0 insider buys, and 12 insider sales for $3.27 million activity. $375,208 worth of ImmunoGen, Inc. (NASDAQ:IMGN) shares were sold by Gregory Richard J.. On Wednesday, February 21 Berkenblit Anna sold $188,540 worth of ImmunoGen, Inc. (NASDAQ:IMGN) or 17,329 shares. BARROWS CRAIG sold $168,618 worth of stock. 11,876 shares valued at $129,211 were sold by Ryll Thomas on Wednesday, February 21. Another trade for 10,000 shares valued at $115,300 was sold by Johnston David Brannon. On Tuesday, February 13 JUNIUS DANIEL M sold $467,253 worth of ImmunoGen, Inc. (NASDAQ:IMGN) or 46,667 shares. 11,379 shares were sold by Wingrove Theresa, worth $123,804.

Analysts await ImmunoGen, Inc. (NASDAQ:IMGN) to report earnings on July, 27. They expect $-0.29 earnings per share, down 190.00% or $0.19 from last year’s $-0.1 per share. After $-0.30 actual earnings per share reported by ImmunoGen, Inc. for the previous quarter, Wall Street now forecasts -3.33% EPS growth.

Investors sentiment increased to 1.38 in 2017 Q4. Its up 0.22, from 1.16 in 2017Q3. It increased, as 26 investors sold IMGN shares while 39 reduced holdings. 37 funds opened positions while 53 raised stakes. 101.53 million shares or 15.77% more from 87.70 million shares in 2017Q3 were reported. Wells Fargo Mn has 1.56M shares. Grp One Trading Ltd Partnership invested in 9,230 shares. 3,397 were accumulated by First Manhattan. Aqr Capital Mngmt Limited Co reported 394,957 shares. Northeast Fincl Consultants Inc holds 0.07% or 34,315 shares. 161,200 are held by Swiss Natl Bank. Trexquant Inv Ltd Partnership holds 0.08% in ImmunoGen, Inc. (NASDAQ:IMGN) or 113,971 shares. Gp Inc, New York-based fund reported 67,280 shares. Fifth Third Commercial Bank has invested 0% of its portfolio in ImmunoGen, Inc. (NASDAQ:IMGN). Renaissance Limited Liability Company reported 1.09M shares. Great West Life Assurance Can invested in 0% or 9,004 shares. The Illinois-based Guggenheim Cap Ltd Llc has invested 0% in ImmunoGen, Inc. (NASDAQ:IMGN). Northern Tru accumulated 1.21M shares. Bb&T Limited Liability stated it has 0.01% in ImmunoGen, Inc. (NASDAQ:IMGN). Natl Bank Of America Corp De accumulated 1.02M shares.

Clearbridge Investments Llc is a New York-based institutional investor with more than $103.00 billion AUM in October, 2014. Clearbridge Investments Llc is the 47th largest institutional investor in our database. Taken from Clearbridge Investments latest Adv, the fund reported to have 178 full and part-time employees. Among which 65 performing investment advisory and research functions. The institutional investor had more than 95900 clients.

Core-Mark Holding Company, Inc. markets fresh and broad-line supply solutions to the convenience retail industry. The company has market cap of $858.46 million. The firm sells and distributes various food/non-food products, including cigarettes, fast food, candies, snacks, groceries, fresh products, dairy products, breads, beverages, other tobacco products, general merchandise and equipment, and health and beauty care products. It has a 25.83 P/E ratio. The Company’s clients include traditional convenience stores, such as national and super-regional convenience store operators, as well as independently owned convenience stores; and alternative outlets, which include grocery stores, drug stores, liquor stores, cigarette and tobacco shops, hotel gift shops, military exchanges, college and corporate campuses, casinos, hardware stores, airport concessions, and other specialty and small format stores that carry convenience products.

Investors sentiment decreased to 1.12 in 2017 Q4. Its down 0.04, from 1.16 in 2017Q3. It dropped, as 10 investors sold CORE shares while 49 reduced holdings. 22 funds opened positions while 44 raised stakes. 41.59 million shares or 3.92% less from 43.28 million shares in 2017Q3 were reported. Quantbot Technologies Lp holds 10,800 shares. Brown Advisory Inc holds 0.23% or 2.31 million shares. Parkside Commercial Bank Trust holds 0% or 19 shares in its portfolio. 75,567 were accumulated by Pinebridge Invs L P. Prtnrs Ltd Co invested 0.01% of its portfolio in Core-Mark Holding Company, Inc. (NASDAQ:CORE). Aqr Capital Limited Liability Co holds 0% in Core-Mark Holding Company, Inc. (NASDAQ:CORE) or 40,571 shares. California State Teachers Retirement Systems invested in 78,068 shares. Blackrock invested in 5.81 million shares. Swiss Retail Bank stated it has 0% in Core-Mark Holding Company, Inc. (NASDAQ:CORE). 75,096 were reported by Comml Bank Of America De. Savings Bank Of Mellon Corp has 712,795 shares for 0.01% of their portfolio. Crawford Invest Counsel holds 33,342 shares. 1,716 are owned by Glenmede Na. Millennium Management Ltd Liability has invested 0% in Core-Mark Holding Company, Inc. (NASDAQ:CORE). Moreover, Great West Life Assurance Can has 0% invested in Core-Mark Holding Company, Inc. (NASDAQ:CORE) for 60,812 shares.

Among 8 analysts covering Core-Mark Holding Company (NASDAQ:CORE), 5 have Buy rating, 0 Sell and 3 Hold. Therefore 63% are positive. Core-Mark Holding Company had 25 analyst reports since August 7, 2015 according to SRatingsIntel. The firm has “Overweight” rating by Stephens given on Wednesday, October 28. On Thursday, August 3 the stock rating was maintained by Jefferies with “Hold”. The stock of Core-Mark Holding Company, Inc. (NASDAQ:CORE) has “Market Perform” rating given on Wednesday, May 9 by BMO Capital Markets. The firm has “Hold” rating given on Friday, March 2 by Stephens. The stock of Core-Mark Holding Company, Inc. (NASDAQ:CORE) has “Hold” rating given on Friday, September 30 by Jefferies. The firm has “Hold” rating given on Monday, January 29 by Jefferies. The stock of Core-Mark Holding Company, Inc. (NASDAQ:CORE) earned “Buy” rating by Raymond James on Friday, January 5. The firm has “Outperform” rating given on Tuesday, August 30 by Raymond James. Jefferies maintained the stock with “Hold” rating in Thursday, October 12 report. The rating was maintained by Jefferies on Thursday, March 1 with “Hold”.

Clearbridge Investments Llc increased Dte Energy Co (NYSE:DTE) stake by 278,440 shares to 279,051 valued at $29.13 million in 2018Q1. It also upped Paypal Hldgs Inc () stake by 189,887 shares and now owns 6.76M shares. Financial Engines Inc (NASDAQ:FNGN) was raised too.

Core-Mark Holding Company, Inc. (NASDAQ:CORE) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.